March 1, 2010 – San Jose, Calif – Santa Clara County has filed a lawsuit against GlaxoSmithKline (GSK), accusing the drugmaker of suppressing evidence that its diabetes drug Avandia causes increased risk of heart attacks.
The lawsuit seeks restitution for all Avandia purchasers in California, claiming the company violated state false advertising statutes.
“GSK’s unlawful conduct has cost patients, their insurers, and government payors millions of dollars, and it has caused needless suffering to thousands of Californians,” said Santa Clara County’s acting county counsel Miguel Marquez. “This is precisely the sort of corporate malfeasance that California law prohibits.”
The lawsuit follows the release of a U.S. Senate report charging that Glaxo minimized Avandia’s safety risks and withheld data from the FDA. Senators said the Senate Finance Committee’s report was based on researchers’ studies of Avandia, internal GSK documents, and FDA documents.
Santa Clara county said that because Glaxo’s Avandia advertising program was aimed at diabetics, who are classified as disabled under California law, they are seeking triple damages.
Contact an Avandia Lawyer
Schmidt & Clark, LLP is currently accepting new Avandia cases throughout the entire United States. Our Defective Drug Litigation Group consists of highly experienced trial lawyers that focus exclusively on the representation of plaintiffs in Avandia lawsuits.
Again, if you or a loved one has experienced negative side effects from taking Avandia, you should contact our law firm immediately by using the form below. You may be entitled to compensation and we can help.